These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25187498)

  • 1. Drug metabolism for the paediatrician.
    de Wildt SN; Tibboel D; Leeder JS
    Arch Dis Child; 2014 Dec; 99(12):1137-42. PubMed ID: 25187498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.
    de Wildt SN
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):935-48. PubMed ID: 21548840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental pharmacology.
    van den Anker JN
    Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of pheno- and genotyping in clinical drug development.
    Zühlsdorf MT
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):607-12. PubMed ID: 9849752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sources of interindividual variability.
    Thummel KE; Lin YS
    Methods Mol Biol; 2014; 1113():363-415. PubMed ID: 24523121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.
    Hines RN
    Int J Pharm; 2013 Aug; 452(1-2):3-7. PubMed ID: 22766445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.
    Leeder JS; Kearns GL; Spielberg SP; van den Anker J
    J Clin Pharmacol; 2010 Dec; 50(12):1377-87. PubMed ID: 20150527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges for drug studies in children: CYP3A phenotyping as example.
    de Wildt SN; Ito S; Koren G
    Drug Discov Today; 2009 Jan; 14(1-2):6-15. PubMed ID: 18721895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction to adverse drug reactions and drug-drug interaction].
    Mikus G
    Ther Umsch; 2011 Jan; 68(1):3-9. PubMed ID: 21184388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.
    Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):207-18. PubMed ID: 22348413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualizing the use of medications in children: making Goldilocks happy.
    Leeder JS; Brown JT; Soden SE
    Clin Pharmacol Ther; 2014 Sep; 96(3):304-6. PubMed ID: 24926777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
    Dorne JL
    Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications.
    Guillemette C; Lévesque É; Rouleau M
    Clin Pharmacol Ther; 2014 Sep; 96(3):324-39. PubMed ID: 24922307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.